Dopamine agonist withdrawal syndrome associated factors: A retrospective chart review
Dopamine agonist withdrawal syndrome (DAWS) has been introduced to describe the constellation of symptoms resulting from reduction or suspension of dopamine agonist medications. In patients with Parkinson’s disease (PD) the impact of DAWS can be significant in terms of distress and disability. Unfor...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | Clinical Parkinsonism & Related Disorders |
Online Access: | http://www.sciencedirect.com/science/article/pii/S259011252200024X |